136 related articles for article (PubMed ID: 11411388)
1. Desirability and feasibility of hepatitis B vaccine in EPI.
Mittal SK
Indian J Pediatr; 2001 Mar; 68 Suppl 1():S61-5. PubMed ID: 11411388
[No Abstract] [Full Text] [Related]
2. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
4. Policy analysis of the use of Hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and Rotavirus vaccines in the national immunization schedules.
Puliyel JM
Health Econ; 2004 Nov; 13(11):1147; author reply 1147-8. PubMed ID: 15547938
[No Abstract] [Full Text] [Related]
5. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Jacobs RJ; Rosenthal P; Meyerhoff AS
Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
Rein DB; Weinbaum CM
Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
[TBL] [Abstract][Full Text] [Related]
7. Costs of running a universal adolescent hepatitis B vaccination programme.
Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
[TBL] [Abstract][Full Text] [Related]
8. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
Eichhorn R
Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
[No Abstract] [Full Text] [Related]
9. Continue to vaccinate against hepatitis B.
Prescrire Int; 2009 Jun; 18(101):131. PubMed ID: 19637437
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis-B vaccination.
Phadke A; Kale A
J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
[No Abstract] [Full Text] [Related]
11. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
[No Abstract] [Full Text] [Related]
12. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
13. What is the best hepatitis B vaccination strategy for South Africa?
Karim SS
S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
[No Abstract] [Full Text] [Related]
14. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B vaccination in the expanded programme of immunization.
Mittal SK; Aggarwal V
Trop Gastroenterol; 1996; 17(3):188-90. PubMed ID: 8987417
[No Abstract] [Full Text] [Related]
16. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
17. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia.
Levin CE; Nelson CM; Widjaya A; Moniaga V; Anwar C
Bull World Health Organ; 2005 Jun; 83(6):456-61. PubMed ID: 15976897
[TBL] [Abstract][Full Text] [Related]
18. [Studies on immunization strategies for hepatitis B in different endemic areas of China].
Wang L; Li H; Wang S; Gong J; Zeng X; Li R; Nong Y; Huang Y; Chen X; Huang Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):104-6. PubMed ID: 11864465
[TBL] [Abstract][Full Text] [Related]
19. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
[TBL] [Abstract][Full Text] [Related]
20. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
